Definitive Healthcare Corp.DHNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+46.9%
5Y CAGR-1.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+46.9%/yr
Quarterly compound
5Y CAGR
-1.1%/yr
Recent acceleration
Percentile
P96
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 31.79% |
| Q3 2025 | -5.21% |
| Q2 2025 | -14.33% |
| Q1 2025 | 3.55% |
| Q4 2024 | 23.35% |
| Q3 2024 | -28.06% |
| Q2 2024 | -0.10% |
| Q1 2024 | -12.42% |
| Q4 2023 | 7.53% |
| Q3 2023 | 5.18% |
| Q2 2023 | 3.49% |
| Q1 2023 | -2.42% |
| Q4 2022 | 10.04% |
| Q3 2022 | 5.73% |
| Q2 2022 | 27.09% |
| Q1 2022 | 19.17% |
| Q4 2021 | 21.11% |
| Q3 2021 | 10.97% |
| Q2 2021 | 12.73% |
| Q1 2021 | 8.52% |
| Q4 2020 | 33.54% |
| Q3 2020 | 5.82% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |